Synergistic interactions between sorafenib and bortezomib in hepatocellular carcinoma involve PP2A-dependent Akt inactivation

Chen K.-F.Yu H.-C.TSUNG-HAO LIUSHOEI-SHENG LEEPEI-JER CHENANN-LII CHENG2021-03-192021-03-1920100168-8278https://www.scopus.com/inward/record.uri?eid=2-s2.0-84984585952&doi=10.1016%2fj.jhep.2009.10.011&partnerID=40&md5=4eb2e1381f26ec2161ab5a87b2ff6043https://scholars.lib.ntu.edu.tw/handle/123456789/553857Synergistic interactions between sorafenib and bortezomib in hepatocellular carcinoma involve PP2A-dependent Akt inactivationjournal article10.1016/j.jhep.2009.10.011199133212-s2.0-84984585952